ArticleThe Journal of biological chemistry2010

Kinetic approach to pathway attenuation using XOMA 052, a regulatory therapeutic antibody that modulates interleukin-1beta activity.

Marina K Roell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.